Synthesis of the Nakanishi Ring-Locked Retinoid
International Journal of Medicinal Chemistry · 2011
DOI: 10.1155/2011/826792 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medicinal Chemistry, 2011. Verfasst von Jamie B Côté und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dalton Medicinal Chemistry Inc., 349 Wildcat Road, Toronto, ON, Canada M3J 2S3. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
An optimized synthetic route to prepare ring-locked retinoid 1a has been developed. We fully describe a purification protocol that provides isomerically pure 1a in support of on-going proof of concept studies for the development of therapeutic agents to treat human ADRP. Additionally, we have found that isomerically pure 1a can be stored in amber vials under argon at − 20 ° C for use over time (up to six months) without degradation. Thus, enabling 1a to be an accessible and valuable biological tool.
Autor:innen und Institutionen
- Dalton Medicinal Chemistry Inc., 349 Wildcat Road, Toronto, ON, Canada M3J 2S3.
- Dalton Pharma Services, 349 Wildcat Road, Toronto, ON, Canada M3J 2S3.
- Bikam Pharmaceuticals Inc., c/o Fidelity Biosciences, 1 Main Street, 13th Floor, Cambridge, MA 02142, USA.
Zitieren
APA
Côté, J. B., Quach, T. D., Demenev, A. P., Garvey, D. S., & Berman, J. M. (2011). Synthesis of the Nakanishi Ring-Locked Retinoid. International Journal of Medicinal Chemistry. https://doi.org/10.1155/2011/826792
Vancouver
Côté JB, Quach TD, Demenev AP, Garvey DS, Berman JM. Synthesis of the Nakanishi Ring-Locked Retinoid. International Journal of Medicinal Chemistry. 2011. doi:10.1155/2011/826792
BibTeX
@article{Ct2011,
author = {Côté, Jamie B and Quach, Tan D and Demenev, Andrey P and Garvey, David S and Berman, Judd M},
title = {Synthesis of the Nakanishi Ring-Locked Retinoid},
journal = {International Journal of Medicinal Chemistry},
year = {2011},
doi = {10.1155/2011/826792}
}
EUVIMED